Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Treasury Shares: 2013-2019

Historic Treasury Shares for Fresenius Medical Care AG (FMS) over the last 1 years, with Q3 2016 value amounting to $6.5 million.

  • Fresenius Medical Care AG's Treasury Shares rose 60460.71% to $410.1 million in Q4 2019 from the same period last year, while for Dec 2019 it was $410.1 million, marking a year-over-year increase of 60460.71%. This contributed to the annual value of $414.9 million for FY2019, which is 58880.87% up from last year.
  • Fresenius Medical Care AG's Treasury Shares amounted to $410.1 million in Q4 2019, which was up 60460.71% from -$95.4 million recorded in Q2 2019.
  • In the past 5 years, Fresenius Medical Care AG's Treasury Shares registered a high of $505.0 million during Q1 2015, and its lowest value of -$505.0 million during Q4 2015.
  • Moreover, its 5-year median value for Treasury Shares was $128.3 million (2017), whereas its average is $110.8 million.
  • Over the last 5 years, Fresenius Medical Care AG's Treasury Shares had its largest YoY gain of 60460.71% in 2019, and its largest YoY loss of 15466.86% in 2019.
  • Quarter analysis of 5 years shows Fresenius Medical Care AG's Treasury Shares stood at -$505.0 million in 2015, then skyrocketed by 110.9% to $55.1 million in 2016, then soared by 132.95% to $128.3 million in 2017, then crashed by 54.62% to $58.2 million in 2018, then skyrocketed by 604.61% to $410.1 million in 2019.
  • Its last three reported values are $6.5 million in Q3 2016, $6.5 million for Q2 2016, and $6.5 million during Q1 2016.